Tamoxifen Initiation After Ductal Carcinoma In Situ

BACKGROUND. Endocrine therapy initiation after ductal carcinoma in situ (DCIS) is highly variable and largely unexplained. National guidelines recommend considering tamoxifen for women with estrogen receptor-positive (ER+) DCIS or who undergo excision alone. We evaluated endocrine therapy use after...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichols, Hazel B., Bowles, Erin J.A., Islam, Jessica, Madziwa, Lawrence, Stürmer, Til, Tran, Diem-Thy, Buist, Diana S.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746086/
https://www.ncbi.nlm.nih.gov/pubmed/26768485
http://dx.doi.org/10.1634/theoncologist.2015-0310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746086/
https://www.ncbi.nlm.nih.gov/pubmed/26768485
http://dx.doi.org/10.1634/theoncologist.2015-0310

Ejemplares similares